Rotavirus vaccines

Kang, G.
October 2006
Indian Journal of Medical Microbiology;Oct2006, Vol. 24 Issue 4, p252
Academic Journal
journal article
Rotavirus, the most common cause of severe diarrhea and a leading cause of mortality in children, has been a priority target for vaccine development for the past several years. The first rotavirus vaccine licensed in the United States was withdrawn because of an association of the vaccine with intussusception. However, the need for a vaccine is greatest in the developing world, because the benefits of preventing deaths due to rotavirus disease are substantially greater than the risk of intussusception. Early vaccines were based on animal strains. More recently developed and licensed vaccines are either animal-human re-assortants or are based on human strains. In India, two candidate vaccines are in the development process, but have not yet reached efficacy trials. Many challenges regarding vaccine efficacy and safety remain. In addition to completing clinical evaluations of vaccines in development in settings with the highest disease burden and virus diversity, there is also a need to consider alternative vaccine development strategies.


Related Articles

  • Rotavirus Vaccine Works.  // Pediatrics for Parents;Mar/Apr2011, Vol. 27 Issue 3/4, p23 

    An abstract of the article "Rotavirus Vaccine Works" is presented.

  • CME QUIZ.  // Pediatric Annals;Aug2004, Vol. 33 Issue 8, p552 

    A quiz regarding combination and rotavirus vaccines is presented.

  • Rotavirus vaccine scheme roll-out.  // Pulse;11/14/2012, Vol. 72 Issue 37, p3 

    The article offers information on the rotavirus vaccine scheme in Great Britain wherein babies under four months will be vaccinated against rotavirus.

  • Rotavirus Vaccine.  // AHFS Consumer Medication Information;Jan2020, p1 

    What is rotavirus? Rotavirus vaccine Who should get rotavirus vaccine and when? Some people should not get rotavirus vaccine or should wait What are the risks from rotavirus vaccine? What if there is a moderate or severe reaction? The National Vaccine Injury Compensation Program How can I learn...

  • Are rotavirus interventions cost-effective globally? Nataro, James // Journal of Refractive Surgery;Mar2003, Vol. 19 Issue 2, p18 

    Discusses the introduction of rotavirus vaccination in developing countries. Statistics on the burden of rotavirus infection; Economic analyses for evaluating medical interventions in the developing world; Cost and the return on investment of rotavirus interventions; Details on the...

  • RotaTeq vaccination highly cost effective in Ghana.  // PharmacoEconomics & Outcomes News;3/3/2012, Issue 648, p3 

    The article reports on a study published in "Vaccine" which revealed the cost effectiveness of rotavirus vaccination that uses the rotavirus W179-9 vaccine for infants in Ghana.

  • Testing new rotavirus vaccines: Efficacy and safety. Marshall, Gary // Journal of Refractive Surgery;Mar2003, Vol. 19 Issue 2, p13 

    Discusses the development of rotavirus vaccines. Characteristics of the Rhesus rotavirus vaccine-tetravalent (RRV-TV); Association of RRV-TV with intussusception; Information on rotavirus vaccines approved by the U.S. Food and Drug Administration.

  • Rotavirus. Parashar, Umesh D.; Bresee, Joseph S.; Gentsch, Jon R.; Glass, Roger I. // Emerging Infectious Diseases;Oct-Dec98, Vol. 4 Issue 4, p561 

    Discusses the biologic and epidemiologic characteristics of rotavirus and the development of rotavirus vaccines. Morphology and classification; Global distribution of rotavirus strains; Epidemiology; Pathogenesis and immunity; Monovalent `Jennerian' vaccines; Bovine vaccines; Rhesus-human...

  • Indirect Benefit of Rotavirus Vaccine.  // Pediatrics for Parents;Mar/Apr2012, Vol. 28 Issue 3/4, p1 

    The article reports on the findings of a study from Northwestern Memorial Hospital that there is an indirect effect of pediatric rotavirus vaccination on rotavirus in adults.

  • Triage calls declined with routine rotavirus vaccination.  // Infectious Disease News;Nov2012, Vol. 25 Issue 11, p42 

    The article reports on a study which found a decrease in cases of rotavirus since the licensure of rotavirus vaccine in 2007.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics